Expanding Assay Portfolio and Drug Discovery Solutions

Our assay portfolio has grown over the past 10 years. With an initial focus on assays for epigenetic enzymes, SAMDI Tech today develops assays capable of screening virtually any enzyme activity with therapeutic implications in immunology, neuroscience, virology, oncology, and beyond.

As the leading provider in label-free assay solutions, we have expanded from exclusively using SAMDI (Self-Assembled Monolayer Desorption Ionization) technology for biochemical enzyme assays to applying SAMDI to high-throughput binding assays. SAMDI Tech also offers capabilities beyond label-free including optical and radioactivity assays. We complement our assay services by offering an in-house small molecule library of over a half-million compounds. We continue to expand our services to offer clients more comprehensive drug discovery solutions, including cell-based assays in 2021.

Company Growth

Over the last 10 years, we’ve had substantial increases in our personnel and laboratory facilities with further expansion on the horizon to better serve our clients.

Key Industry Connections and Recognition

After beginning with early adopters of SAMDI in 2011, SAMDI Tech has contributed to drug discovery programs in big pharma, biotechs, government labs, and academic collaborators around the world. We continue to provide thought leadership within the industry, having authored and contributed to more than 10 peer-reviewed journals and collaborated on dozens of posters and oral presentations at international conferences.

Over the past decade, we’ve formed several strategic partnerships with other leading industry organizations, and we were named a Specialized Center of Excellence by the National Cancer Institute in 2016.

SAMDI Tech Inc. A Decade of Excellence

Commitment to the Future

As we look toward the future of drug discovery, SAMDI Tech promises to deliver unrivaled, comprehensive solutions through expert technical knowledge, advanced assay technologies, communication, the highest quality data, and rapid turnaround time.